Hikma Pharmaceuticals PLC (ADR)
General ticker "HKMPY" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $5.7B (TTM average)
Hikma Pharmaceuticals PLC (ADR) does not follow the US Stock Market performance with the rate: -25.8%.
Estimated limits based on current volatility of 0.8%: low 41.24$, high 42.01$
Factors to consider:
- Company pays dividends (semi-annually): last record date 2025-08-18, amount 0.72$ (Y3.47%)
Short-term HKMPY quotes
Long-term HKMPY plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2,517.00MM | $2,875.00MM | $3,127.00MM |
| Operating Expenses | $2,235.00MM | $2,508.00MM | $2,515.00MM |
| Operating Income | $282.00MM | $367.00MM | $612.00MM |
| Non-Operating Income | $-49.00MM | $-86.00MM | $-158.00MM |
| Interest Expense | $70.00MM | $87.00MM | $88.00MM |
| R&D Expense | $144.00MM | $149.00MM | $141.00MM |
| Income(Loss) | $233.00MM | $281.00MM | $454.00MM |
| Taxes | $42.00MM | $89.00MM | $93.00MM |
| Profit(Loss)* | $188.00MM | $190.00MM | $359.00MM |
| Stockholders Equity | $2,135.00MM | $2,198.00MM | $2,310.00MM |
| Inventory | $776.00MM | $891.00MM | $986.00MM |
| Assets | $4,471.00MM | $4,680.00MM | $5,133.00MM |
| Operating Cash Flow | $530.00MM | $608.00MM | $564.00MM |
| Capital expenditure | $225.00MM | $204.00MM | $235.00MM |
| Investing Cash Flow | $-607.00MM | $-333.00MM | $-381.00MM |
| Financing Cash Flow | $-58.00MM | $-337.00MM | $-188.00MM |
| Earnings Per Share** | $1.68 | $1.71 | $3.24 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.